BIO-key International is trading at $2.94, up +7.37%, amid its October 28 announcement of an additional deployment in a Middle East government’s national-security ecosystem.

  • The release did not name the customer, disclose contract value, or provide a schedule.
  • The announcement is a plausible company-specific catalyst, but the release did not explicitly link it to the pre-market move.
  • Broader markets were mixed: the Nasdaq was up 0.37% and the Dow was down 0.18%. No pre-market volume was available in the sources reviewed.